The Molecular Biology of Myeloma
David S. Siegel, MD, PhD
Video Categories: Targeted Therapies
Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
John Hennessy discusses the benefits of the “personalized medicine toolkit” to help make better decisions
Grant Lawless discusses the definition of value in personalized medicine from different perspectives